Vertex Pharmaceuticals Incorporated shares owned by Quadrant Capital
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Quadrant Capital
from 13F filings
Historical chart of Quadrant Capital investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Quadrant Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $981k | 2.3k | 418.01 |
| 2023-12-31 | $944k | 2.3k | 406.89 |
| 2023-09-30 | $781k | 2.2k | 347.74 |
| 2023-06-30 | $796k | 2.3k | 351.91 |
| 2023-03-31 | $738k | 2.3k | 315.07 |
| 2022-12-31 | $579k | 2.0k | 288.78 |
| 2022-09-30 | $583k | 2.0k | 289.76 |
| 2022-06-30 | $522k | 1.9k | 282.01 |
| 2022-03-31 | $397k | 1.5k | 260.84 |
| 2021-12-31 | $312k | 1.4k | 219.41 |
| 2021-09-30 | $216k | 1.2k | 181.21 |
| 2021-06-30 | $270k | 1.3k | 201.49 |
| 2021-03-31 | $312k | 1.5k | 214.88 |
| 2020-12-31 | $336k | 1.4k | 236.62 |
| 2020-09-30 | $344k | 1.3k | 271.94 |
| 2020-06-30 | $363k | 1.2k | 290.63 |
| 2020-03-31 | $598k | 2.5k | 238.10 |
| 2019-12-31 | $401k | 2.1k | 190.48 |
| 2019-09-30 | $268k | 1.9k | 142.86 |
| 2019-06-30 | $259k | 1.8k | 142.86 |
| 2019-03-31 | $281k | 1.5k | 181.82 |
| 2018-12-31 | $78k | 853 | 90.91 |
| 2018-09-30 | $124k | 684 | 181.82 |
| 2018-06-30 | $59k | 653 | 90.91 |
| 2018-03-31 | $112k | 701 | 160.00 |
| 2017-12-31 | $57k | 627 | 90.91 |
| 2017-09-30 | $57k | 624 | 90.91 |
| 2017-06-30 | $70k | 587 | 120.00 |
| 2017-03-31 | $52k | 522 | 100.00 |
| 2016-12-31 | $0 | 458 | 0.00 |
| 2016-09-30 | $44k | 555 | 80.00 |
| 2016-06-30 | $40k | 503 | 80.00 |
| 2016-03-31 | $31k | 437 | 70.00 |
| 2015-12-31 | $110k | 955 | 115.38 |
| 2015-09-30 | $101k | 977 | 103.33 |
| 2015-06-30 | $107k | 892 | 120.00 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated